RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 1 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,416,000 | -78.1% | 318,121 | -53.3% | 0.04% | -78.5% |
| Q4 2019 | $6,467,000 | +12.7% | 680,764 | -6.9% | 0.16% | +30.4% |
| Q3 2019 | $5,737,000 | -47.8% | 730,890 | +4.7% | 0.12% | -54.9% |
| Q2 2019 | $10,986,000 | +14.6% | 698,402 | +31.9% | 0.28% | +1.1% |
| Q1 2019 | $9,586,000 | +89.1% | 529,615 | +68.1% | 0.27% | +33.0% |
| Q4 2018 | $5,068,000 | +12.2% | 315,152 | +67.4% | 0.21% | +50.4% |
| Q3 2018 | $4,518,000 | – | 188,268 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $11,652,000 | 19.67% |
| Flagship Pioneering Inc. | 38,296,526 | $170,419,000 | 7.99% |
| HARBOURVEST PARTNERS LLC | 986,878 | $4,392,000 | 2.12% |
| Abbot Financial Management, Inc. | 563,500 | $2,508,000 | 2.04% |
| Artal Group S.A. | 3,883,791 | $17,283,000 | 0.73% |
| ARK Investment Management | 318,121 | $1,416,000 | 0.04% |
| Walleye Capital LLC | 34,000 | $151,000 | 0.03% |
| Tekla Capital Management LLC | 155,982 | $694,000 | 0.03% |
| Baillie Gifford | 4,256,900 | $18,943,000 | 0.02% |
| FEDERATED HERMES, INC. | 600,000 | $2,670,000 | 0.01% |